Indication
Malaria
Code ICD11:
1F4Z
INN
Amodiaquine + sulfadoxine + pyrimethamine
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Solid > dispersible tablet:
76.5 mg (as hydrochloride) [3] + 250 mg + 12.5 mg [1] in co-package
(EMLc)
;
153 mg (as hydrochloride) [3] + 500 mg + 25 mg [1] in co-package
(EMLc)
;
75 mg (as hydrochloride) [3] + 250 mg + 12.5 mg [1] in co-package
(EMLc)
;
150 mg (as hydrochloride) [3] + 500 mg + 25 mg [1] in co-package
(EMLc)
Historique des statuts LME
Sexe
Tous
Âge
Enfants (1 mois - 12 ans)
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of new strengths of co-packaged amodiaquine with sulfadoxine + pyrimethamine to the EMLc for seasonal malaria chemoprevention in children.